|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5575 | |
| A61K 31/557 | |||
| A61P 27/06 | |||
| A61K 9/00 | |||
| A61K 9/16 | |||
| A61K 9/70 |
| (11) | Number of the document | 2411013 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10723400.7 |
| Date of filing the European patent application | 2010-03-25 | |
| (97) | Date of publication of the European application | 2012-02-01 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/028584 |
| Date | 2010-03-25 |
| (87) | Number | WO 2010/111449 |
| Date | 2010-09-30 |
| (30) | Number | Date | Country code |
| 41125009 | 2009-03-25 | US |
| (72) |
ROBINSON, Michael R., US
BURKE, James A., US
LIU, Hui, US
ORILLA, Werhner C., US
SPADA, Lon T., US
WHITCUP, Scott, US
GHEBREMESKEL, Alazar N., US
HUGHES, Patrick M., US
XU, Kun, US
DO, Marianne M., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | INTRACAMERAL SUSTAINED RELEASE DRUG DELIVERY SYSTEMS |
| INTRACAMERAL SUSTAINED RELEASE DRUG DELIVERY SYSTEMS |